tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Syntara Limited Raises A$15 Million Through New Share Issuance
Company AnnouncementsSyntara Limited Raises A$15 Million Through New Share Issuance
3d ago
Syntara Limited Announces New Security Issuance on ASX
PremiumCompany Announcements
Syntara Limited Announces New Security Issuance on ASX
3d ago
Syntara’s SNT-6302 Shows Promising Results in Scar Treatment Trial
PremiumCompany Announcements
Syntara’s SNT-6302 Shows Promising Results in Scar Treatment Trial
5d ago
Pharmaxis Ltd General Meeting Addresses Key Resolutions
PremiumCompany Announcements
Pharmaxis Ltd General Meeting Addresses Key Resolutions
7d ago
Syntara Limited Announces New Company Secretary Amid Ongoing Drug Development Initiatives
PremiumCompany Announcements
Syntara Limited Announces New Company Secretary Amid Ongoing Drug Development Initiatives
17d ago
Pharmaxis Ltd Reveals Interim Results at Hematology Forum
PremiumCompany AnnouncementsPharmaxis Ltd Reveals Interim Results at Hematology Forum
19d ago
Syntara Reports Promising Interim Results for Myelofibrosis Treatment
Premium
Company Announcements
Syntara Reports Promising Interim Results for Myelofibrosis Treatment
26d ago
Syntara Limited Reports Positive Cash Flow Despite Operating Outflows
Premium
Company Announcements
Syntara Limited Reports Positive Cash Flow Despite Operating Outflows
26d ago
Syntara Limited Announces ASX Quotation of Securities
PremiumCompany Announcements
Syntara Limited Announces ASX Quotation of Securities
1M ago
Syntara Limited Seeks Shareholder Approval for $15M Capital Raise
PremiumCompany Announcements
Syntara Limited Seeks Shareholder Approval for $15M Capital Raise
1M ago
Syntara Limited Announces New Securities Issue Plan
PremiumCompany Announcements
Syntara Limited Announces New Securities Issue Plan
2M ago
Syntara Limited to Issue 250 Million Shares
PremiumCompany Announcements
Syntara Limited to Issue 250 Million Shares
2M ago
Pharmaxis Ltd Announces New Equity Raising Initiative
PremiumCompany AnnouncementsPharmaxis Ltd Announces New Equity Raising Initiative
2M ago
Syntara Ltd Secures A$15 Million for Clinical Trials
Premium
Company Announcements
Syntara Ltd Secures A$15 Million for Clinical Trials
2M ago
Syntara Limited’s SNT-5505 Shows Promise in Myelofibrosis Trial
Premium
Company Announcements
Syntara Limited’s SNT-5505 Shows Promise in Myelofibrosis Trial
3M ago
Syntara Prepares to Unveil Promising Myelofibrosis Data
PremiumCompany Announcements
Syntara Prepares to Unveil Promising Myelofibrosis Data
3M ago
Syntara Limited Prepares for Interim Trial Data Release
PremiumCompany Announcements
Syntara Limited Prepares for Interim Trial Data Release
3M ago
Pharmaxis Ltd Director Increases Stock Options
PremiumCompany Announcements
Pharmaxis Ltd Director Increases Stock Options
3M ago
Syntara Limited Secures Shareholder Support in Key Resolutions
PremiumCompany Announcements
Syntara Limited Secures Shareholder Support in Key Resolutions
3M ago
Pharmaxis Ltd: A Powerhouse of Pharmaceutical Expertise
PremiumCompany AnnouncementsPharmaxis Ltd: A Powerhouse of Pharmaceutical Expertise
3M ago
Syntara Limited’s Bold Transformation and Future Prospects
Premium
Company Announcements
Syntara Limited’s Bold Transformation and Future Prospects
3M ago
Syntara Limited to Present Promising Cancer Trial Results
Premium
Company Announcements
Syntara Limited to Present Promising Cancer Trial Results
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >